Works matching AU Naito, Yoichi

Results: 83
    1
    2

    Current Status of Advance Care Planning and End‐of‐life Communication for Patients with Advanced and Metastatic Breast Cancer.

    Published in:
    Oncologist, 2021, v. 26, n. 4, p. e686, doi. 10.1002/onco.13640
    By:
    • Sagara, Yasuaki;
    • Mori, Masanori;
    • Yamamoto, Sena;
    • Eguchi, Keiko;
    • Iwatani, Tsuguo;
    • Naito, Yoichi;
    • Kogawa, Takahiro;
    • Tanaka, Kiyo;
    • Kotani, Haruru;
    • Yasojima, Hiroyuki;
    • Ozaki, Yukinori;
    • Noguchi, Emi;
    • Miyasita, Minoru;
    • Kondo, Naoto;
    • Niikura, Naoki;
    • Toi, Masakazu;
    • Shien, Tadahiko;
    • Iwata, Hiroji
    Publication type:
    Article
    3
    4

    Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study.

    Published in:
    Breast Cancer (13406868), 2022, v. 29, n. 6, p. 1088, doi. 10.1007/s12282-022-01390-w
    By:
    • Kotani, Haruru;
    • Masuda, Norikazu;
    • Yamashita, Toshinari;
    • Naito, Yoichi;
    • Taira, Tetsuhiko;
    • Inoue, Kenichi;
    • Takahashi, Masato;
    • Yonemori, Kan;
    • Toyoizumi, Shigeyuki;
    • Mori, Yuko;
    • Nagasawa, Takashi;
    • Hori, Natsuki;
    • Iwata, Hiroji
    Publication type:
    Article
    5
    6

    Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer.

    Published in:
    Breast Cancer (13406868), 2022, v. 29, n. 1, p. 131, doi. 10.1007/s12282-021-01290-5
    By:
    • Taira, Naruto;
    • Kashiwabara, Kosuke;
    • Tsurutani, Junji;
    • Kitada, Masahiro;
    • Takahashi, Masato;
    • Kato, Hiroaki;
    • Kikawa, Yuichiro;
    • Sakata, Eiko;
    • Naito, Yoichi;
    • Hasegawa, Yoshie;
    • Saito, Tsuyoshi;
    • Iwasa, Tsutomu;
    • Takashima, Tsutomu;
    • Aihara, Tomohiko;
    • Mukai, Hirofumi;
    • Hara, Fumikata
    Publication type:
    Article
    7

    Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.

    Published in:
    2021
    By:
    • Shimoi, Tatsunori;
    • Nagai, Shigenori E.;
    • Yoshinami, Tetsuhiro;
    • Takahashi, Masato;
    • Arioka, Hitoshi;
    • Ishihara, Mikiya;
    • Kikawa, Yuichiro;
    • Koizumi, Kei;
    • Kondo, Naoto;
    • Sagara, Yasuaki;
    • Takada, Masahiro;
    • Takano, Toshimi;
    • Tsurutani, Junji;
    • Naito, Yoichi;
    • Nakamura, Rikiya;
    • Hattori, Masaya;
    • Hara, Fimikata;
    • Hayashi, Naoki;
    • Mizuno, Toshiro;
    • Miyashita, Minoru
    Publication type:
    Correction Notice
    8

    The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.

    Published in:
    Breast Cancer (13406868), 2020, v. 27, n. 3, p. 322, doi. 10.1007/s12282-020-01085-0
    By:
    • Shimoi, Tatsunori;
    • Nagai, Shigenori E.;
    • Yoshinami, Tetsuhiro;
    • Takahashi, Masato;
    • Arioka, Hitoshi;
    • Ishihara, Mikiya;
    • Kikawa, Yuichiro;
    • Koizumi, Kei;
    • Kondo, Naoto;
    • Sagara, Yasuaki;
    • Takada, Masahiro;
    • Takano, Toshimi;
    • Tsurutani, Junji;
    • Naito, Yoichi;
    • Nakamura, Rikiya;
    • Hattori, Masaya;
    • Hara, Fimikata;
    • Hayashi, Naoki;
    • Mizuno, Toshiro;
    • Miyashita, Minoru
    Publication type:
    Article
    9
    10
    11

    Chronological improvement in precision oncology implementation in Japan.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 3995, doi. 10.1111/cas.15517
    By:
    • Sunami, Kuniko;
    • Naito, Yoichi;
    • Komine, Keigo;
    • Amano, Toraji;
    • Ennishi, Daisuke;
    • Imai, Mitsuho;
    • Kage, Hidenori;
    • Kanai, Masashi;
    • Kenmotsu, Hirotsugu;
    • Koyama, Takafumi;
    • Maeda, Takahiro;
    • Morita, Sachi;
    • Sakai, Daisuke;
    • Kohsaka, Shinji;
    • Tsuchihara, Katsuya;
    • Saigusa, Yusuke;
    • Yoshino, Takayuki
    Publication type:
    Article
    12

    Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 3646, doi. 10.1111/cas.15504
    By:
    • Imai, Mitsuho;
    • Nakamura, Yoshiaki;
    • Sunami, Kuniko;
    • Kage, Hidenori;
    • Komine, Keigo;
    • Koyama, Takafumi;
    • Amano, Toraji;
    • Ennishi, Daisuke;
    • Kanai, Masashi;
    • Kenmotsu, Hirotsugu;
    • Maeda, Takahiro;
    • Morita, Sachi;
    • Sakai, Daisuke;
    • Bando, Hideaki;
    • Makiyama, Akitaka;
    • Suzuki, Tatsuya;
    • Hirata, Makoto;
    • Kohsaka, Shinji;
    • Tsuchihara, Katsuya;
    • Naito, Yoichi
    Publication type:
    Article
    13
    14

    Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA.

    Published in:
    Cancer Science, 2021, v. 112, n. 9, p. 3911, doi. 10.1111/cas.15022
    By:
    • Sunami, Kuniko;
    • Bando, Hideaki;
    • Yatabe, Yasushi;
    • Naito, Yoichi;
    • Takahashi, Hideaki;
    • Tsuchihara, Katsuya;
    • Toyooka, Shinichi;
    • Mimori, Koshi;
    • Kohsaka, Shinji;
    • Uetake, Hiroyuki;
    • Kinoshita, Ichiro;
    • Komine, Keigo;
    • Takeda, Masayuki;
    • Hayashida, Tetsu;
    • Tamura, Kenji;
    • Nishio, Kazuto;
    • Yamamoto, Noboru
    Publication type:
    Article
    15
    16
    17

    Clinical practice guidance for next‐generation sequencing in cancer diagnosis and treatment (Edition 1.0).

    Published in:
    Cancer Science, 2018, v. 109, n. 9, p. 2980, doi. 10.1111/cas.13730
    By:
    • Sunami, Kuniko;
    • Takahashi, Hideaki;
    • Tsuchihara, Katsuya;
    • Takeda, Masayuki;
    • Suzuki, Tatsuya;
    • Naito, Yoichi;
    • Sakai, Kazuko;
    • Dosaka‐Akita, Hirotoshi;
    • Ishioka, Chikashi;
    • Kodera, Yasuhiro;
    • Muto, Manabu;
    • Wakai, Toshifumi;
    • Yamazaki, Kentaro;
    • Yasui, Wataru;
    • Bando, Hideaki;
    • Fujimoto, Yumi;
    • Fukuoka, Shota;
    • Harano, Kenichi;
    • Kawazoe, Akihito;
    • Kimura, Gen
    Publication type:
    Article
    18
    19
    20
    21
    22

    Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan.

    Published in:
    JAMA Network Open, 2022, v. 5, n. 12, p. e2245081, doi. 10.1001/jamanetworkopen.2022.45081
    By:
    • Naito, Yoichi;
    • Sunami, Kuniko;
    • Kage, Hidenori;
    • Komine, Keigo;
    • Amano, Toraji;
    • Imai, Mitsuho;
    • Koyama, Takafumi;
    • Ennishi, Daisuke;
    • Kanai, Masashi;
    • Kenmotsu, Hirotsugu;
    • Maeda, Takahiro;
    • Morita, Sachi;
    • Sakai, Daisuke;
    • Watanabe, Kousuke;
    • Shirota, Hidekazu;
    • Kinoshita, Ichiro;
    • Yoshioka, Masashiro;
    • Mamesaya, Nobuaki;
    • Ito, Mamoru;
    • Kohsaka, Shinji
    Publication type:
    Article
    23
    24

    A double‐blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy‐induced nausea and vomiting in patients with breast cancer receiving anthracycline and cyclophosphamide

    Published in:
    Cancer Medicine, 2020, v. 9, n. 10, p. 3319, doi. 10.1002/cam4.2979
    By:
    • Matsumoto, Koji;
    • Takahashi, Masato;
    • Sato, Kazuhiko;
    • Osaki, Akihiko;
    • Takano, Toshimi;
    • Naito, Yoichi;
    • Matsuura, Kazuo;
    • Aogi, Kenjiro;
    • Fujiwara, Kimiko;
    • Tamura, Kenji;
    • Baba, Motoi;
    • Tokunaga, Shinya;
    • Hirano, Gen;
    • Imoto, Shigeru;
    • Miyazaki, Chieko;
    • Yanagihara, Kazuhiro;
    • Imamura, Chiyo K.;
    • Chiba, Yasutaka;
    • Saeki, Toshiaki
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32

    First‐in‐human study of E7130 (a tumor microenvironment‐ameliorating microtubule inhibitor) in patients with advanced solid tumors: Primary results of the dose‐escalation part.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 15, p. 2348, doi. 10.1002/cncr.34788
    By:
    • Doi, Toshihiko;
    • Matsubara, Nobuaki;
    • Naito, Yoichi;
    • Kuboki, Yasutoshi;
    • Harano, Kenichi;
    • Ono, Makiko;
    • Urasaki, Tetsuya;
    • Ohmoto, Akihiro;
    • Kawanai, Tsubasa;
    • Hisai, Takashi;
    • Ikezawa, Hiroki;
    • Shiba, Sari;
    • Ito, Ken;
    • Semba, Taro;
    • Asano, Osamu;
    • Takahashi, Shunji
    Publication type:
    Article
    33

    HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis.

    Published in:
    2022
    By:
    • Tan, Ryan Shea Ying Cong;
    • Ong, Whee Sze;
    • Lee, Kyung-Hun;
    • Lim, Abner Herbert;
    • Park, Seri;
    • Park, Yeon Hee;
    • Lin, Ching-Hung;
    • Lu, Yen-Shen;
    • Ono, Makiko;
    • Ueno, Takayuki;
    • Naito, Yoichi;
    • Onishi, Tatsuya;
    • Lim, Geok-Hoon;
    • Tan, Su-Ming;
    • Lee, Han-Byoel;
    • Ryu, Han Suk;
    • Han, Wonshik;
    • Tan, Veronique Kiak Mien;
    • Wong, Fuh-Yong;
    • Im, Seock-Ah
    Publication type:
    journal article
    34

    Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1).

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 2, p. 233, doi. 10.1007/s10147-020-01831-6
    By:
    • Naito, Yoichi;
    • Aburatani, Hiroyuki;
    • Amano, Toraji;
    • Baba, Eishi;
    • Furukawa, Toru;
    • Hayashida, Tetsu;
    • Hiyama, Eiso;
    • Ikeda, Sadakatsu;
    • Kanai, Masashi;
    • Kato, Motohiro;
    • Kinoshita, Ichiro;
    • Kiyota, Naomi;
    • Kohno, Takashi;
    • Kohsaka, Shinji;
    • Komine, Keigo;
    • Matsumura, Itaru;
    • Miura, Yuji;
    • Nakamura, Yoshiaki;
    • Natsume, Atsushi;
    • Nishio, Kazuto
    Publication type:
    Article
    35

    Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 3, p. 403, doi. 10.1007/s10147-019-01610-y
    By:
    • Naito, Yoichi;
    • Mishima, Saori;
    • Akagi, Kiwamu;
    • Igarashi, Ataru;
    • Ikeda, Masafumi;
    • Okano, Susumu;
    • Kato, Shunsuke;
    • Takano, Tadao;
    • Tsuchihara, Katsuya;
    • Terashima, Keita;
    • Nishihara, Hiroshi;
    • Nishiyama, Hiroyki;
    • Hiyama, Eiso;
    • Hirasawa, Akira;
    • Hosoi, Hajime;
    • Maeda, Osamu;
    • Yatabe, Yasushi;
    • Okamoto, Wataru;
    • Ono, Shigeru;
    • Kajiyama, Hiroaki
    Publication type:
    Article
    36
    37
    38
    39

    Prognostic factors of HER2-positive breast cancer patients who develop brain metastasis: a multicenter retrospective analysis.

    Published in:
    Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 277, doi. 10.1007/s10549-014-3237-7
    By:
    • Hayashi, Naoki;
    • Niikura, Naoki;
    • Masuda, Norikazu;
    • Takashima, Seiki;
    • Nakamura, Rikiya;
    • Watanabe, Ken-ichi;
    • Kanbayashi, Chizuko;
    • Ishida, Mayumi;
    • Hozumi, Yasuo;
    • Tsuneizumi, Michiko;
    • Kondo, Naoto;
    • Naito, Yoichi;
    • Honda, Yayoi;
    • Matsui, Akira;
    • Fujisawa, Tomomi;
    • Oshitanai, Risa;
    • Yasojima, Hiroyuki;
    • Yamauchi, Hideko;
    • Saji, Shigehira;
    • Iwata, Hiroji
    Publication type:
    Article
    40
    41

    Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis.

    Published in:
    Breast Cancer Research & Treatment, 2014, v. 147, n. 1, p. 103, doi. 10.1007/s10549-014-3090-8
    By:
    • Niikura, Naoki;
    • Hayashi, Naoki;
    • Masuda, Norikazu;
    • Takashima, Seiki;
    • Nakamura, Rikiya;
    • Watanabe, Ken-ichi;
    • Kanbayashi, Chizuko;
    • Ishida, Mayumi;
    • Hozumi, Yasuo;
    • Tsuneizumi, Michiko;
    • Kondo, Naoto;
    • Naito, Yoichi;
    • Honda, Yayoi;
    • Matsui, Akira;
    • Fujisawa, Tomomi;
    • Oshitanai, Risa;
    • Yasojima, Hiroyuki;
    • Tokuda, Yutaka;
    • Saji, Shigehira;
    • Iwata, Hiroji
    Publication type:
    Article
    42
    43
    44
    45
    46

    The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434).

    Published in:
    Investigational New Drugs, 2021, v. 39, n. 1, p. 152, doi. 10.1007/s10637-020-00942-1
    By:
    • Doi, Toshihiko;
    • Fujiwara, Yutaka;
    • Shitara, Kohei;
    • Shimizu, Toshio;
    • Yonemori, Kan;
    • Matsubara, Nobuaki;
    • Ohno, Izumi;
    • Kogawa, Takahiro;
    • Naito, Yoichi;
    • Leopold, Lance;
    • Munteanu, Mihaela;
    • Yatsuzuka, Naoyoshi;
    • Han, Shi Rong;
    • Samkari, Ayman;
    • Yamamoto, Noboru
    Publication type:
    Article
    47
    48
    49

    The Impact of Carboplatin Dosing Design Using Adjusted Serum Creatinine on Carboplatin Plus Paclitaxel Therapy for Ovarian Cancer.

    Published in:
    Cancer Medicine, 2025, v. 14, n. 7, p. 1, doi. 10.1002/cam4.70804
    By:
    • Kato, Shu;
    • Baba, Kaede;
    • Mamishin, Kanako;
    • Uematsu, Mao;
    • Shimura, Mai;
    • Hirota, Akira;
    • Fukuda, Misao;
    • Takahashi, Nobuyuki;
    • Nakao, Takehiro;
    • Nakajima, Hiromichi;
    • Funasaka, Chikako;
    • Kondoh, Chihiro;
    • Harano, Kenichi;
    • Naito, Yoichi;
    • Matsubara, Nobuaki;
    • Hosono, Ako;
    • Kawasaki, Toshikatsu;
    • Mukohara, Toru
    Publication type:
    Article
    50